Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]CTT1057 PET imaging in biochemical recurrence of prostate cancer
NCT04838613Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of vidoflufolastat (18F), sponsored by Novartis. Started Sep 2021; status: completed.
02
Drugs
vidoflufolastat (18F)
Beyond the preview
Go deeper on NCT04838613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838613.